Jeffrey Wong, Ph. D.

Dr. Jeffrey Wong, Ph. D., is a distinguished international scientist and co-developer of Dextran-Hemoglobin.

Dr. Wong is currently Adjunct Professor, Department of Biochemistry, Hong Kong University of Science and Technology, and Director of the university’s Applied Genomics Laboratory. He is a member of the Board of Directors of Dextro-Sang Corporation.

Dr. Wong, a Canadian citizen, received a Bachelor’s degree in physiology and biochemistry in 1959 and a Ph.D. in biochemistry in 1963 from the University of Toronto. He subsequently held positions of Assistant Professor (1965-1968), Associate Professor (1968-1976), and Professor (1976-1990) in the university’s Department of Biochemistry. In 1990, Dr. Wong became the Founding Head and Professor of the Department of Biochemistry at the Hong Kong University of Science and Technology, and the Founding Director of the Biotechnology Research Institute at the university. From 1995 to 2000, he was Director of the university’s Drug Delivery Centre.

Dr. Wong has published more than 40 articles in scientific journals and is a member of the Society for Biochemistry and Molecular Biology, the Federation of American Societies for Experimental Biology, and the International Committee on Blood Substitutes of ISABL (International Society of Artificial Cells, Blood Substitutes and Immobilization Biotechnology).

Mario Moscarello, M.D., Ph. D.
Professor Emeritus, University of Toronto
and Hospital for Sick Children, Toronto, Canada.

Dr. Kampon Sriwatanakul, M.D., Ph.D

Dr. Kampon Sriwatanakul, M.D., Ph.D., is an internationally recognized Thai pharmacologist who is supervising the clinical testing of Dextran-Hemoglobin in Thailand.

Dr. Sriwatanakul is an Associate Professor in the Department of Pharmacology at Mahidol University, Thailand’s premier teaching institution in medicine. He is a consultant to the Thai Food and Drug Administration, and a member of several Subcommittees appointed by the Ministry of Public Health. He is also Adjunct Scholar at the Center for the Study of Drug Development at Tufts University in Boston.

Dr. Sriwatanakul received a Bachelor’s degree in medical science in 1972, a Doctor of Medicine degree in 1974, and a Ph.D. in pharmacology in 1978 from Mahidol University. He became a medical scholar and professor at the university and was appointed in 1984 as Chairman of the Department of Pharmacology and Director of the Toxicology Graduate Program – posts he held until 1988. Subsequent appointments at the university have included Deputy Dean of the Faculty of Graduate Studies (1988-1989 and 1992-1995), Assistant to the President on Foreign Relations and Research (1989-1990), and Vice-President on Research and Foreign Relations (1990-1991).

During his academic career, Dr. Sriwatanakul gained international recognition as a drug-development specialist through his scientific publications and research appointments in British and U.S. universities. He has been a British Council Research Fellow in pharmacology at the University of Leicester (1978-1979) and a British Council Visiting Scientist in clinical pharmacology at the University of Edinburgh (1987-1988), and received a cancer study grant from the Royal Marsden Hospital in Sutton, England (1988-1989). He also has been a Merck International Fellow in clinical pharmacology at University of Rochester in the United States (1981-1982).

Dr. Sriwatanakul is a member of the Medical Association of Thailand, the Pharmacological and Therapeutic Society of Thailand, and the Toxicological Society of Thailand.